Diversification Rating
10 /10
Expense Ratio Rating
10 /10
Expense Rating
9 /10
Market Score
10 /10
Category Score
0 /10
Market Size
10 /10
$XLV Alternatives
Different Funds
We found 10,815 Sector Equity Healthcare funds. Here they are ordered by FI Score.
- tmnax
- Mutual Fund
- Bond
- Municipal Bond
Counterpoint Tactical Municipal Fund Class A
Expenses: 1.25% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- tnacx
- Mutual Fund
- Allocation
- Target-Date
Invesco Balanced-Risk Retirement 2030 Fund Class C
Expenses: 1.00% (Better than 0% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
- uipix
- Mutual Fund
- Alternatives
- Inverse
ProFunds UltraShort Mid-Cap Fund Investor Class
Expenses: 1.78% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternatives fund. See why »
- uspvx
- Mutual Fund
- US Stocks
- Large Value
Union Street Partners Value Fund Class A Shares
Expenses: 1.60% (Better than 0% of similar funds)
This is a bad choice for a Large Value US Stocks fund. See why »
- vrecx
- Mutual Fund
- Allocation
- Target-Date
Invesco Balanced-Risk Retirement 2030 Fund Class CX
Expenses: 1.00% (Better than 0% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
- whycx
- Mutual Fund
- Bond
- Municipal Bond
Wells Fargo High Yield Municipal Bond Fund - Class C
Expenses: 1.55% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- xmpt
- ETF
- Bond
- Municipal Bond
VanEck Vectors CEF Municipal Income ETF
Expenses: 1.86% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- aiafx
- Mutual Fund
- Allocation
- Global Equity
Aberdeen Global Infrastructure Fund Class A
Expenses: 1.45% (Better than 0% of similar funds)
This is a bad choice for a Global Equity Allocation fund. See why »
- amgcx
- Mutual Fund
- US Stocks
- Mid-Cap Growth
Alger Mid Cap Growth Fund Class C
Expenses: 2.14% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »